Inventor · Somerville, MA, US

Nicolas Cedric Boyer

15Patents
3h-index
62Co-inventors
59Inventor score

Filing activity: Jun 25, 2010 → Sep 27, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9353150B2 Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment Chemistry; Metallurgy 9 Active
US10220099B2 Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment Chemistry; Metallurgy 6 Active
US11530244B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 4 Active
US10918735B2 Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment Chemistry; Metallurgy 3 Active
US9644004B2 Peptide and peptidomimetic inhibitors Human Necessities 1 Active
US9238676B2 Peptide and peptidomimetic inhibitors Human Necessities 1 Active
US10272132B2 Peptide and peptidomimetic inhibitors Human Necessities 1 Active
US8309341B2 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them Chemistry; Metallurgy 0 Active
US12365706B2 Macrocyclic peptides as potent inhibitors of K-RAS G12D mutant Chemistry; Metallurgy 0 Active
US11814444B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 0 Active
US9999650B2 Peptide and peptidomimetic inhibitors Human Necessities 0 Active
US11932705B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 0 Active
US12012468B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 0 Active
US11505575B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 0 Active
US11814445B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.